Search Results 1181-1190 of 13321 for monoclonal antibody

1. Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155) - Mayo Clinic

   Has had prior anti-cancer monoclonal antibody within 4 weeks of Study Day 1 or who has not recovered from adverse events due to agents administered >4 weeks ...

2. Evaluate Risk/Benefit Of Nab Paclitaxel In Combination With Gemcitabine And Carboplatin Compared To Gemcitabine And Carboplatin In Triple Negative Metastatic Breast Cancer (Or Metastatic Triple Negative Breast Cancer) - Mayo Clinic

   Prior immunotherapy & monoclonal antibody therapy are acceptable. Subjects who received prior cytotoxic chemotherapy after incomplete resection of ...

3. A Phase 1/​2 Study Of STP938 For Adult Subjects With Relapsed/​Refractory B-Cell And T-Cell Lymphomas - Mayo Clinic

   study drug. - Systemic cancer treatments, monoclonal antibody-directed therapies, other investigational agents within 4 weeks before enrollment, or <5 half ...

4. A Study To Evaluate The Effect Of Canakinumab Or Pembrolizumab Given As Monotherapy Or In Combination As Neo-adjuvant Treatment For Subjects With Early Stages NSCLC - Mayo Clinic

   -History of severe hypersensitivity reactions to monoclonal antibodies ... antibody or drug specifically targeting T-cell co-stimulation or immune ...

5. Against extraordinary odds: A life saved more than once - Mayo Clinic News Network

   Iyer prescribed a monoclonal antibody-based therapy typically used for severe asthma that stabilized his lungs and kept his transplant on track — until ...

6. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, And Dexamethasone To Pomalidomide And Dexamethasone In Refractory Or Relapsed And Refractory Multiple Myeloma Patients - Mayo Clinic

   Isatuximab is a monoclonal antibody that binds a specific epitope on the human CD38 receptor and has antitumour activity via multiple mechanisms of action.

7. A Study Assessing HMB-002 In Participants With Von Willebrand Disease - Mayo Clinic

   History of clinically significant hypersensitivity associated with monoclonal antibody therapies. Personal history of venous or arterial thrombosis or ...

8. The VITAL Amyloidosis Study, A Global Phase 3, Efficacy And Safety Study Of NEOD001 In Patients With AL Amyloidosis - Mayo Clinic

   History of Grade ≥ 3 infusion-associated AEs or hypersensitivity to another monoclonal antibody, or known hypersensitivity to diphenhydramine or acetaminophen ...

9. A Study Of LY2951742 In Participants With Chronic Cluster Headache - Mayo Clinic

   Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins. A history or presence of other medical illness that indicates ...

10. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...